| Date Filed | Type | Description |
| 04/10/2019 |
GN
| New Research Coverage Highlights Fortive, Pieris Pharmaceuticals, CEVA, ManTech International, Cerus, and NN — Consolidated Revenues, Company Growth, and Expectations for 2019 |
| 02/14/2019 |
GN
| Consolidated Research: 2019 Summary Expectations for Varonis, Dolby Laboratories, Alder BioPharmaceuticals, Retail Properties of America, Cerus, and Motorcar Parts of America — Fundamental Analysis, Key Performance Indications |
| 05/08/2018 |
BW
| Cerus Corporation Reports First Quarter 2018 Results |
| 04/25/2018 |
BW
| Cerus to Release First Quarter 2018 Results on May 8, 2018 |
| 03/08/2018 |
BW
| Cerus Corporation Reports Record Fourth Quarter and Year End 2017 Results |
| 03/07/2018 |
BW
| Cerus to Present at the Cowen and Company 38th Annual Health Care Conference on March 13, 2018 |
| 02/22/2018 |
BW
| Cerus to Release Fourth Quarter and Year End 2017 Results on March 8, 2018 |
| 01/08/2018 |
BW
| Cerus Corporation Announces Preliminary Product Revenue Results for Fourth Quarter and Full Year 2017 |
| 11/22/2017 |
GN
| Factors of Influence in 2018, Key Indicators and Opportunity within REV Group, CoreLogic, M/I Homes, Halyard Health, Deckers Outdoor, and Cerus — New Research Emphasizes Economic Growth |
| 11/02/2017 |
BW
| Cerus Corporation Reports Third Quarter 2017 Results |
| 10/19/2017 |
BW
| Cerus to Release Third Quarter 2017 Results on November 2, 2017 |
| 08/30/2017 |
BW
| Cerus to Present at Two Upcoming Conferences |
| 08/03/2017 |
BW
| Cerus Corporation Reports Second Quarter 2017 Results |
| 07/21/2017 |
BW
| Cerus to Release Second Quarter 2017 Results on August 3, 2017 |
| 05/03/2017 |
BW
| Cerus Corporation Reports First Quarter 2017 Results |
| 04/19/2017 |
BW
| Cerus to Release First Quarter 2017 Results on May 3, 2017 |
| 04/07/2017 |
GN
| Cerus Corporation (Nasdaq: CERS) to Ring the Nasdaq Stock Market Closing Bell Remotely from the Nasdaq Entrepreneurial Center in San Francisco |
| 03/07/2017 |
BW
| Cerus Corporation Reports Fourth Quarter and Year End 2016 Results |
| 03/02/2017 |
BW
| Cerus to Present at the Cowen and Company 37th Annual Health Care Conference on March 8, 2017 |
| 02/21/2017 |
BW
| Cerus to Release Fourth Quarter and Year End 2016 Results on March 7, 2017 |
| 08/18/2011 |
BW
| Cerus Awarded $2.1 Million to Advance Development of Pathogen Inactivation for Red Blood Cells |
| 07/12/2011 |
BW
| Cerus to Release Second Quarter 2011 Results on July 28, 2011 |
| 06/29/2011 |
BW
| Cerus Corporation Announces Changes to Board of Directors |
| 06/09/2011 |
BW
| Cerus Corporation and Ilex Biotech LTD Initiate Distribution Agreements for the INTERCEPT Blood System in South Africa and Israel |
| 05/31/2011 |
BW
| Cerus to Present at the Jefferies 2011 Global Healthcare Conference |
| 04/28/2011 |
BW
| Cerus Corporation Announces First Quarter 2011 Financial Results |
| 04/20/2011 |
BW
| Cerus Appoints William "Obi" Greenman as President and Chief Executive Officer |
| 04/12/2011 |
BW
| Cerus to Release First Quarter 2011 Results on April 28, 2011 |
| 03/03/2011 |
BW
| Cerus Corporation Reports Fourth Quarter and Year-End 2010 Results |
| 03/01/2011 |
BW
| Cerus to Present at the Cowen and Company 31st Annual Health Care Conference |
| 02/25/2011 |
BW
| Cerus to Release Fourth Quarter and Year-End 2010 Results on March 3, 2011 |
| 02/18/2011 |
BW
| Cerus Corporation Postpones Fourth Quarter & Year-End 2010 Earnings Release and Conference Call |
| 02/16/2011 |
BW
| Cerus' INTERCEPT Plasma Granted Orphan Drug Designation for Treatment of Thrombotic Thrombocytopenic Purpura (TTP) |
| 11/16/2010 |
BW
| Cerus' INTERCEPT Blood System for Plasma Receives Swiss Approval |
|